The role of metformin in dysplastic mucosa of the larynx: A follow up study
Metformin is a safe agent that has the potential to prevent progression of laryngeal dysplasia in patients with a history of HNSCC. Further studies are needed to verify and expand on this limited case series.
Authors
- Corina Din‐Lovinescu (ORCID: https://orcid.org/0000-0002-0299-3697)
- Diana S. Shaari (ORCID: https://orcid.org/0000-0002-0851-5311)
- Marshall Strome
- Diana N. Kirke (ORCID: https://orcid.org/0000-0002-9289-3875)
- Andrew Blitzer
Institutions
- University of Phoenix (US)
- ENT and Allergy (US)
- Hackensack Meridian Health (US)
- Allergy Associates Research Center (US)
- Icahn School of Medicine at Mount Sinai (US)
Publication Details
- Journal
- American Journal of Otolaryngology
- Published
- 2025-12-12
- DOI
- https://doi.org/10.1016/j.amjoto.2025.104769
- Primary Topic
- Voice and Speech Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00